Glucagon‐Like Peptide‐1 Receptor Agonist Use and the Risk of Adverse Cardiac and Kidney Outcomes Among Patients With Systemic Lupus Erythematosus and Lupus Nephritis

Arthritis &Rheumatology, Volume 78, Issue 3, Page 665-671, March 2026.

Criar conta gratuita para acessar o conteúdo completo